Clinical manifestations | NMO-IgG positive (n = 16) | NMO-IgG negative (n = 7) | |
---|---|---|---|
F/M | 13/3 | 6/1 | |
Duration of disease | 0-4 y | 6 | 2 |
5-9 y | 5 | 2 | |
10- y | 5 | 3 | |
Brain lesion(n) | Â | Â | |
 Brain lobes | 8 | 7 | |
 Basal ganglia | 3 | 2 | |
 Hypothalamic and thalamic | 4 | 2 | |
 Mesencephalon | 1 | 1 | |
 Pons | 5 | 3 | |
 Medulla oblongata | 4 | 2 | |
 Peri-ventricle and peri-aqueduct | 4 | 3 | |
 Cerebellum | 3 | 0 | |
Spinal cord lesions(n) | Â | Â | |
LETM | 21 | 5 | |
STM | 8 | 4 | |
Focal atrophy of SC | 14 | 5 | |
General atrophy of SC | 6 | 3 | |
Atrophy of STM | 13 | 3 | |
Atrophy of LETM | 9 | 4 |